Why the study?
Because moderate variability and accelerations are physiologically similar and equally indicative of a non-acidemic fetus, the authors evaluated whether interpreting NSTs based on variability rather than accelerations produces similar results.
Does interpreting non-stress tests based on moderate variability predict fetal well-being in singleton fetuses at increased risk of fetal demise?
Does interpreting non-stress tests based on moderate variability predict fetal well-being in singleton fetuses at increased risk of fetal demise?
In non-anomalous fetuses, moderate variability in an otherwise non-reactive non-stress test is highly predictive of fetal well-being, suggesting additional follow-up testing may be unnecessary.
Answers are grounded in this paper and cite their sources.
May support reduced follow-up after non-reactive non-stress tests with moderate variability; hypothesis-generating for prospective validation of variability-based criteria.
Background: Accelerations were initially chosen as the basis for non-stress test (NST) interpretation against a background of significant artifact present in first generation non-autocorrelated fetal monitors that made the interpretation of variability with external fetal heart rate monitoring unreliable. Since moderate variability and accelerations are physiologically similar and equally indicative of a non-acidemic fetus, we hypothesized that interpreting NSTs based on variability rather than accelerations would produce similar results. Study Design: We performed a retrospective cohort study of singleton fetuses undergoing antenatal testing in our system between 2011 and 2022. Data regarding interpretation of non-stress tests was extracted and non-reactive tests were identified. For patients with non-reactive non-stress tests, data regarding follow up testing were collected. Results: Our cohort included 76,232 total non-stress tests performed on 22,619 patients at increased risk of fetal demise, of which 1,662 (2%) were found to be non-reactive. Of the non-reactive tests, 1,499 (90%) were interpreted as having moderate variability, 114 (7%) had minimal or absent variability, and in 49 (3%) the variability was uncertain. Data regarding follow up testing was available for 1,480 of the 1499 non-reactive tests with moderate variability. In this group, 1,476 (99%) went on to have either reassuring follow up testing or a non-acidemic cord gas value at birth. The four infants (0.3%) who failed to have a reassuring follow up test all had major anomalies. Conclusion: In non-anomalous fetuses, moderate variability in an otherwise non-reactive non-stress test was invariably followed by a reassuring test of fetal well-being. These data confirm basic science observations regarding fetal heart rate regulation and suggest that, in the presence of moderate variability during an otherwise nonreactive non-stress test, additional follow up testing may not be necessary. Such an approach would avoid the need for additional testing in 90% of fetuses with non-reactive non-stress tests
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: